Bronchiolitis Obliterans Syndrome (BOS) Terminated Phase 2 Trials for Bortezomib D-mannitol (DB16741)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01163786A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHDTreatment